Research brief
Elevance Health closed the week ended 19 June at 388.5 USD, down 3.9%, with volume at 7.0M shares, or 0.9x the 13-week average. The weekly Trend backdrop is active for a sixth week and price remains 12.2% above the Trend Line, but short-term momentum has cooled and the stock sits 4.8% below Sharemaestro Fair Value.
- ELV fell 3.9% for the week and is down 1.1% over four weeks, despite a 36.2% 12-week gain.
- The stock remains in an active weekly Trend Signal, closing 12.2% above the 346.4 USD Trend Line, but 9.0% below its 52-week high of 427.0 USD.
- Healthcare Plans breadth is strong, with 81.8% active Trend signals, 90.9% positive Market Dynamics and 81.8% positive Relative Strength, yet ELV ranked only 8th of 11 in the industry for the week.
- Participation was muted at 7.0M shares, below the 8.2M 13-week average and 9.3M 52-week average.
Pullback interrupts a strong quarter
Elevance Health’s latest weekly close at 388.5 USD leaves the stock high in its one-year range, at 75.8% between the 268.0 USD low and 427.0 USD high, but the immediate price action has lost urgency. The shares fell 3.9% in the latest completed week and are now down 1.1% over four weeks, even after a 36.2% 12-week advance and a 15.2% 26-week gain.
The signal state is still constructive rather than broken. Sharemaestro’s weekly Trend backdrop remains active, with a six-week active streak, and the close is 12.2% above the 346.4 USD Trend Line. The mixed point is valuation distance: the stock is still 4.8% below Sharemaestro Fair Value at 408.2 USD, suggesting the market has not fully endorsed the recent recovery.
Healthcare Plans breadth is healthier than ELV’s weekly rank
The sector context is mixed. US Healthcare declined 1.4% on average for the week, with only 31.0% of sector constituents in active weekly trends and just 25.0% showing positive Relative Strength. Elevance did worse than the sector on the week, ranking in the weaker end of the broader US Healthcare peer set at 829 of 1,028.
The industry read is sharper. US Healthcare Plans posted a softer 1.3% average weekly decline, but breadth remains unusually firm: 81.8% active Trend signals, 90.9% positive Market Dynamics and 81.8% positive Relative Strength. ELV’s 3.9% fall placed it 8th of 11 in the group for the week and its four-week return of -1.1% trails the industry’s 12.5% average. That gap matters because peers such as Clover Health, Alignment Healthcare and Oscar Health are still showing much stronger short-term follow-through, while ELV sits closer to the laggard cluster with Cigna and Centene.
Market Dynamics stay positive, but confirmation is measured
Sharemaestro Market Dynamics remain supportive, with activity pressure positive at 0.97 and Relative Strength at 5.08. Both reads keep the stock on the constructive side of the ledger, but they have cooled from early June levels, when activity pressure was 1.06 and Relative Strength was 12.73. Expectancy is classed as Undecided at 51.19%, which fits the balanced setup rather than a clean continuation profile.
Volume does not yet argue for forceful sponsorship of the next move. Latest turnover was 7.0M shares, below the 8.2M 13-week average and 9.3M 52-week average, producing a 0.9x short-term volume ratio and 0.8x one-year ratio. The prior week’s 2.3% decline came on 9.7M shares, so the two-week setback has not been accompanied by a decisive accumulation signal.
Risk profile and what to watch next
Risk is moderate by recent standards. Thirteen-week weekly-return volatility is 3.6%, below the 52-week baseline of 5.0%, while the one-year up/down split is 29 positive weeks versus 23 negative weeks. The average positive week has been 3.5%, against an average negative week of -3.9%, leaving the loss skew slightly heavier even though upside weeks have been more frequent.
The watch points are straightforward: whether ELV can stabilise above the rising Trend Line, whether activity pressure stops fading, and whether volume expands above ordinary levels on any attempted recovery. A move back toward Fair Value near 408.2 USD would test demand after the pullback, while failure to defend the current premium to trend would make the 9.0% drawdown from the high more relevant.
Research note
This article is for educational market research only and is not financial, investment, trading, tax, or legal advice. Sharemaestro does not make buy, sell, or hold recommendations.
Source and attribution
Source: Sharemaestro. Canonical article: https://sharemaestro.com/news/elv-weekly-drop-healthcare-plans-breadth-light-volume/.
Media and research systems can follow the RSS feed or JSON feed.